Amgen
Generative AI platform for pharmaceutical R&D
Drug discovery is one of the most complex, resource-intensive processes in pharma — traditionally years of manual research, testing and trial-and-error. Amgen wanted to bring generative AI into that workflow.
The problem
The goal was to transform a manual, time-intensive process into a data-driven, AI-enhanced system delivering faster, more accurate results without compromising scientific rigor or safety.
- 01Integrating generative AI models into Amgen's R&D workflow
- 02Analyzing large, complex biomedical datasets efficiently
- 03Predicting optimal molecular structures for targeted therapies
- 04Suggesting potential drug candidates with greater precision
- 05Ensuring compliance with pharmaceutical regulations and ethical AI standards
- 06Shortening research timelines without compromising scientific rigor
What we did
AI development
Built generative AI models capable of simulating and predicting molecular interactions.
AI data analytics
Trained models on large-scale biomedical datasets for improved accuracy.
AI compliance
Ensured AI-driven processes adhered to FDA, EMA and industry guidelines for safety and transparency.
AI platform integration
Embedded AI into Amgen's existing R&D infrastructure for seamless adoption.
Iterative implementation
Collaborated closely with Amgen's research teams to refine algorithms and align with scientific goals.
Model validation
Cross-checked predictions against known outcomes to build researcher trust.
What shipped
Generative AI models
Predict new molecular structures with high therapeutic potential.
Data-driven recommendations
Analyze billions of data points to suggest promising drug candidates.
Molecule design acceleration
Automate complex design tasks that traditionally required years of manual work.
Integrated AI compliance layer
Built-in safeguards to align with pharmaceutical regulations.
Scalable AI platform
Adaptable to multiple therapeutic areas and research pipelines.
Research team tooling
Interfaces letting scientists review and act on AI-generated candidates.
- Accelerated research timelines — molecule design and evaluation reduced from years to months
- Improved precision in predicting molecular viability and drug candidate success
- Enhanced productivity by freeing researchers from repetitive tasks
- A scalable platform adaptable for future research projects across therapeutic categories
- Positioned Amgen as a pioneer in applying generative AI to pharmaceutical discovery
- Built-in compliance reducing friction between R&D and regulatory review
- →AI development for pharmaceutical research
- →Integrating generative AI models into regulated industries
- →Building compliant AI platforms that accelerate scientific innovation
- →AI data analytics and implementation expertise for global enterprises
- →Regulatory alignment has to be designed in, not bolted on
- →Scientist trust depends on validation, not just model accuracy
Work with an AI development partner in healthcare
Looking to leverage AI for drug discovery, healthcare analytics or pharmaceutical research? We specialize in AI platform development, compliance and implementation.
Start a conversation →